Doctor profile · Federal record

Dr. Norman Gebrosky, MD

Urology Physician (CMS: Urology) · Latrobe, PA

  • NPI 1659476224
  • Accepts Medicare
  • MIPS 100.0 / 100 · 2023
  • 30 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
911 Ligonier St Ste 104
Latrobe, PA 156501805
(724) 539-9736
fax (724) 539-2836

Credentials & registration

NPPES · NUCC
NPI registered
September 2006 — 20 yrs on file
Profile last updated
May 12, 2017
Year of graduation
1996 — 30 yrs since
Specialty taxonomy
208800000X — NUCC code
State license (1)
Pennsylvania #MD058568L
Medicaid
PA #1594279

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1659476224. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
3,994
Distinct HCPCS
10
Medicare allowed
$293,937
HCPCS Description Services Patients Avg allowed
J1952 Leuprolide injectable, camcevi, 1 mg 966 16 $84
87798 Detection test by nucleic acid for organism, amplified probe technique 442 30 $34
81002 Urinalysis, manual test 438 358 $3
99214 Established patient office or other outpatient visit, 30-39 minutes 408 332 $124
99213 Established patient office or other outpatient visit, 20-29 minutes 375 329 $88
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes 219 96 $78
87481 Detection test for candida species (yeast), amplified probe technique 170 30 $34
81000 Manual urinalysis test with examination using microscope, non-automated 130 119 $4
51798 Ultrasound measurement of bladder capacity after voiding 117 106 $10
87801 Detection test by nucleic acid for multiple organisms, amplified probe(s) technique 102 30 $69

In context: peer comparison

Among 3 peers in Latrobe Urology Physician, average services per provider: 160. This provider delivers 25× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$738
Transactions
63
Manufacturers
14
Payer (manufacturer) Industry Txns Amount
Sumitomo Pharma America, INC. 37 $261.28
Astellas Pharma US INC 6 $107.77
Janssen Biotech, INC. 3 $73.25
Myriad Genetic Laboratories, INC. 4 $67.01
Antares Pharma, INC. 2 $31.59
Procept BioRobotics Corporation 1 $31.37
AstraZeneca Pharmaceuticals Lp 2 $31.17
Urogen Pharma, INC. 2 $27.12
Merck Sharp & Dohme LLC 1 $22.29
Cumberland Pharmaceuticals, INC. 1 $19.53
Bayer Healthcare Pharmaceuticals INC. 1 $19.49
Tolmar, INC. 1 $16.81
Ferring Pharmaceuticals INC. 1 $15.07
Pfizer INC. 1 $14.49

By nature of payment

Food and Beverage
$738

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
928
Patients
552
Total drug cost
$1,245,226
Drug Type Claims Patients Total cost
Tamsulosin Hcl Generic 150 77 $4,109
Sulfamethoxazole-Trimethoprim (Sulfamethoxazole/Trimethoprim) Brand 135 110 $409
Finasteride Generic 81 38 $1,778
Xtandi (Enzalutamide) Brand 73 11 $1,025,476
Tramadol Hcl Generic 72 59 $135
Orgovyx (Relugolix) Brand 68 11 $171,976
Oxybutynin Chloride Generic 64 52 $621
Nitrofurantoin Mono-Macro (Nitrofurantoin Monohyd/M-Cryst) Brand 56 49 $687
Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) Brand 45 45 $216
Levofloxacin Generic 43 40 $106

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Norman Gebrosky's medical specialty?
Dr. Norman Gebrosky practices Urology Physician in Latrobe, PA.
Where does Dr. Norman Gebrosky practice?
Dr. Norman Gebrosky practices at 911 Ligonier St Ste 104, Latrobe, PA 156501805. Office phone: 7245399736.
What is Dr. Norman Gebrosky's NPI?
Dr. Norman Gebrosky's National Provider Identifier (NPI) is 1659476224, issued by NPPES.
Does Dr. Norman Gebrosky accept Medicare assignment?
Yes. Dr. Norman Gebrosky accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Norman Gebrosky commonly perform?
Top Medicare-reported procedures in 2023: Leuprolide injectable, camcevi, 1 mg (HCPCS J1952); Detection test by nucleic acid for organism, amplified probe technique (HCPCS 87798); Urinalysis, manual test (HCPCS 81002). Source: CMS Medicare Physician & Other Practitioners file.